Research Background & Mechanism
Thymosin Beta-4 is an actin-binding regenerative peptide with a molecular weight of 4963.5 Da. Understanding its mechanism — binds and sequesters G-actin to regulate cytoskeletal dynamics and cell migration — matters because it defines which experimental models the peptide is suited for and which controls a lab should run.
For researchers designing a protocol, the practical takeaway is to match the peptide to a specific, testable hypothesis rather than to a broad research area. Thymosin Beta-4 is most consistently cited in work on cell migration, tissue repair and wound-healing models, angiogenesis, so that is where the published literature will give you the most guidance.
Purity & Quality Standards
The baseline specification for TB-500 should be ≥98% by HPLC with MS confirmation and TFA salt removal. High-performance liquid chromatography reports the purity percentage, while mass spectrometry confirms that the material is actually Thymosin Beta-4 at the expected molecular weight (4963.5 Da) — the two checks are complementary, not redundant.
Beyond purity, verify the salt form and any residue from synthesis (such as TFA removal) on the certificate of analysis. These details are easy to overlook but can shift results in sensitive assays, so they are part of any serious supplier-verification checklist.
Storage & Handling
The correct storage condition for TB-500 is lyophilized at -20°C, stable 12–24 months. Lyophilized peptide held at this temperature keeps its stated purity far longer than material left at ambient temperature, and the difference is measurable over months of routine use.
Once reconstituted, stability drops quickly, so laboratories should refrigerate solutions and use them within the window defined by their own protocol. Plan reconstitution just before use rather than in advance.
Sourcing & Supplier Verification
A reliable TB-500 supplier should provide a batch-specific COA showing HPLC ≥98% and an MS spectrum at 4963.5 Da, and should be transparent about synthesis capacity and lead times. Suppliers that cannot produce these documents are the primary source of sub-standard or mis-identified material.
For bulk research purchasing, request the COA before committing to a large order, and confirm the peptide is sold strictly for laboratory and research use. A supplier that markets research peptides with therapeutic language is a red flag for compliance.
Frequently Asked Questions
Q1: What is the difference between TB-500 and Thymosin Beta-4?
TB-500 is the synthetic research fragment of Thymosin Beta-4; labs cite both names, but verify the exact sequence and MW on the COA before ordering, since they are not always interchangeable in experimental design.
Q2: What purity should I require for TB-500?
Require ≥98% HPLC with mass-spectrometry confirmation. Anything lower, or a supplier that won’t share the COA, should be rejected for reproducibility-sensitive protocols.
Q3: How should TB-500 be stored for maximum shelf life?
Keep it lyophilized and sealed at -20°C; once reconstituted, keep refrigerated and use promptly, because peptide stability drops quickly in solution.
Important: All products are sold strictly for laboratory and research purposes only — not for human or veterinary use. No medical, therapeutic, or dosing guidance is provided or implied. Researchers are responsible for compliance with their institution and local regulations.
📞 WhatsApp: +852 4419 8097 — batch-specific COA documents, bulk research pricing, and current stock for your lab.